Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of liposome bupivacaine for pain control after total knee arthroplasty
ChiCTR2300074631Phase 4Not yet recruiting
- Sponsor
- Heze Municipal Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in knee osteoarthritis (OA) (2 arms), sponsored by Heze Municipal Hospital. Primary endpoints: Postoperative pain and sedation scores and Postoperative opioid consumption and PCIA use. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2300074631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074631.